APLT vs TMO · rev $455.0K vs P/E 24, rev $23.00B
Applied Therapeutics Inc (APLT) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Applied Therapeutics Inc (APLT) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported APLT revenue for 2024-12-31 was $455.0K. Net income was -$105.6M. APLT currently screens at market cap $14.9M.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
APLT currently screens at market cap $14.9M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the APLT and TMO stock pages for the full models.
Not investment advice.